Research from Doulatov Lab in the Journal Blood Offers Stem Cell-Aided Insights on MDS Onset

June 13, 2019 | Categories: Research | Tagged: , ,

Myelodysplastic syndromes (MDS) are heterogenous blood disorders that affect up to 170,000 people in the United States, primarily over the age of 60. While early symptoms, including anemia (characterized by fatigue), are not serious, MDS is a high-risk factor for leukemia. Currently there are few treatment for MDS and the causes remain poorly understood. Read More

Blood researcher receives NIH New Innovator Award

October 3, 2018 | Categories: Announcements | Tagged: ,

The National Institutes of Health today announced that stem cell biologist Sergei Doulatov, assistant professor of medicine, Division of Hematology, at the University of Washington School of Medicine will receive an NIH Director’s New Innovator Award. The award is part of the NIH’s High Risk, High Reward Research Program which allocates funding to support unusually inventive research by scientists in the early stages of their careers. Read More